Sidley represented Caidya, a leading global mid-sized CRO, in its US$165 million strategic growth investment from funds managed by Rubicon Founders, a U.S.-based healthcare investment firm focused on building and growing transformational companies.
The investment will support the next phase of Caidya’s growth story, enabling continued organic expansion along with exploration of strategic acquisitions.
The Sidley team was led by partner Ruchun Ji. Other team members included partner Feifei Bian, senior managing associate Jing Peng, and China advisor Pan Chen. Partners Olivia Ngan, Andrew Shoyer and senior managing associate Jonathan Westreich also provided support.
In a separate transaction, Sidley also advised Caidya in connection with its credit facilities with a global banking institution. The Sidley team was led by partners Olivia Ngan, Ruchun Ji, and included managing associate Kelly Lam and legal manager Kenny Wong.
Sidley’s Global Life Sciences practice, which comprises more than 200 dedicated lawyers globally, offers cross-disciplinary, full-service solutions for life science clients, including M&A and private equity, licensing and collaboration transactions, capital markets, regulatory compliance and enforcement, and dispute resolutions, assisting biotech and pharmaceutical clients around the world. Sidley’s China Life Sciences practice, an integral part of the firm’s Global Life Sciences practice, is the only Band One international firm ranked by Chambers Asia Pacific/Greater China Region for 15 consecutive years.
